High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening

被引:0
|
作者
Chang, Yu-Fen [1 ]
Su, Wan-Chi [1 ]
Su, Chih-Chuan [1 ]
Chung, Min-Wen [1 ]
Chang, Jin [2 ]
Li, You-Yi [3 ]
Kao, Yi-Ju [3 ]
Chen, Wen-Pin [3 ]
Daniels, Matthew J. [4 ,5 ,6 ]
机构
[1] LumiSTAR Biotechnol Inc, Taipei, Taiwan
[2] NEXEL Co Ltd, Seoul, South Korea
[3] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan
[4] Manchester Univ NHS Fdn Trust, Manchester Royal Infirm, Manchester Heart Ctr, Manchester, Lancs, England
[5] Univ Manchester, Manchester Acad Hlth Sci Ctr, Div Cardiovasc Sci, Manchester, Lancs, England
[6] Univ Manchester, Div Cell Matrix Biol & Regenerat Med, Manchester, Lancs, England
来源
关键词
STEM-CELLS; EXPRESSION; INDICATORS; PROMOTER;
D O I
10.3791/63175
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Understanding how excitable cells work in health and disease and how that behavior can be altered by small molecules or genetic manipulation is important. Genetically encoded calcium indicators (GECIs) with multiple emission windows can be combined (e.g., for simultaneous observation of distinct subcellular events) or used in extended applications with other light-dependent actuators in excitable cells (e.g., combining genetically encoded optogenetic control with spectrally compatible calcium indicators). Such approaches have been used in primary or stem cellderived neurons, cardiomyocytes, and pancreatic beta-cells. However, it has been challenging to increase the throughput, or duration of observation, of such approaches due to limitations of the instruments, analysis software, indicator performance, and gene delivery efficiency. Here, a high-performance green GECI, mNeonGreen-GECO (mNG-GECO), and red-shifted GECI, K-GECO, is combined with optogenetic control to achieve all-optical control and visualization of cellular activity in a high-throughput imaging format using a High-Content Imaging System. Applications demonstrating cardiotoxicity testing and phenotypic drug screening with healthy and patient-derived iPSC-CMs are shown. In addition, multi-parametric assessments using combinations of spectral and calcium affinity indicator variants (NIR-GECO, LAR-GECO, and mtGCEPIA or Orai1-G-GECO) are restricted to different cellular compartments are also demonstrated in the iPSC-CM model.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Evaluation of human iPS cell-derived cardiomyocytes in high-throughput toxicity screening applications
    Ameen, Caroline
    Dahlenborg, Kerstin
    Akesson, Karolina
    Flood, Maria
    Aspegren, Anders
    Juhasz, Krisztina
    Stoelzle-Feix, Sonja
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2018, 93 : 161 - 161
  • [22] Evaluation of human iPS cell-derived cardiomyocytes in high-throughput toxicity screening applications
    Cho, Gunsik
    Kwon, Hyosung
    Kim, Dongkyu
    Horvath, Andras
    Becker, Nadine
    Juhasz, Krisztina
    Dragicevic, Elena
    Stoelzle-Feix, Sonja
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2020, 105
  • [23] Using Transcriptomics for Biomarker Discovery Enabling High-Throughput Drug Screening of iPSC-Cardiomyocytes Modeling a Cardiomyopathy
    Rowland, Teisha J.
    Hashem, Sherin I.
    Jones, Kenneth
    Bonham, Andrew J.
    Jett, Susan
    Adler, Eric
    LaBarbera, Daniel
    Mestroni, Luisa
    Taylor, Matthew
    [J]. FASEB JOURNAL, 2017, 31
  • [24] High-Throughput Assays for Phenotypic Analyses and Drug Screening of hiPSC-Derived Neurons
    Bang, Anne
    Hinckley, Sandy
    Biesmans, Steven
    Sherman, Sean
    Zhou, Haowen
    Pre, Deborah
    [J]. BIOLOGICAL PSYCHIATRY, 2017, 81 (10) : S291 - S291
  • [25] Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes
    Lapp, Hendrik
    Bruegmann, Tobias
    Malan, Daniela
    Friedrichs, Stephanie
    Kilgus, Carsten
    Heidsieck, Alexandra
    Sasse, Philipp
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [26] Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes
    Hendrik Lapp
    Tobias Bruegmann
    Daniela Malan
    Stephanie Friedrichs
    Carsten Kilgus
    Alexandra Heidsieck
    Philipp Sasse
    [J]. Scientific Reports, 7
  • [27] A multiparametric calcium signal screening platform using iPSC-derived cortical neural spheroids
    Boutin, Molly E.
    Strong, Caroline E.
    Van Hese, Brittney
    Hu, Xin
    Itkin, Zina
    Chen, Yu-Chi
    LaCroix, Andrew
    Gordon, Ryan
    Guicherit, Oivin
    Carromeu, Cassiano
    Kundu, Srikanya
    Lee, Emily
    Ferrer, Marc
    [J]. SLAS DISCOVERY, 2022, 27 (04) : 209 - 218
  • [28] Small Molecule Regulators of microRNAs in Human iPSC-derived Neurons Identified by High-Throughput Screen Coupled High-Throughput Sequencing
    Nguyen, Lien
    Wei, Zhiyun
    Silva, M. Catarina
    Barberan-Soler, Sergio
    Muratore, Christina
    Young-Pearse, Tracy
    Haggarty, Stephen
    Krichevsky, Anna
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (03) : S83 - S83
  • [29] A new platform for high-throughput therapy testing on iPSC-derived lung progenitor cells from cystic fibrosis patients
    Jiang, Jia Xin
    Wellhauser, Leigh
    Laselva, Onofrio
    Utkina, Irina
    Bozoky, Zoltan
    Gunawardena, Tarini
    Ngan, Zoe
    Xia, Sunny
    Di Paola, Michelle
    Eckford, Paul D. W.
    Ratjen, Felix
    Moraes, Theo J.
    Parkinson, John
    Wong, Amy P.
    Bear, Christine E.
    [J]. STEM CELL REPORTS, 2021, 16 (11): : 2825 - 2837
  • [30] Hypothesis Testing in High-Throughput Screening for Drug Discovery
    Prummer, Michael
    [J]. JOURNAL OF BIOMOLECULAR SCREENING, 2012, 17 (04) : 519 - 529